Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 34 points (-0.2%) at 18,106 as of Monday, Feb. 23, 2015, 12:10 PM ET. The NYSE advances/declines ratio sits at 1,298 issues advancing vs. 1,669 declining with 161 unchanged.

The Materials & Construction industry currently sits down 0.1% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Boise Cascade ( BCC), down 4.2%, Clean Harbors ( CLH), down 1.9%, Quanta Services ( PWR), down 2.2%, Eagle Materials ( EXP), down 1.4% and Chicago Bridge & Iron Company ( CBI), down 1.7%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Cemex SAB de CV ( CX) is one of the companies pushing the Materials & Construction industry lower today. As of noon trading, Cemex SAB de CV is down $0.04 (-0.5%) to $9.92 on light volume. Thus far, 2.1 million shares of Cemex SAB de CV exchanged hands as compared to its average daily volume of 15.4 million shares. The stock has ranged in price between $9.82-$9.93 after having opened the day at $9.91 as compared to the previous trading day's close of $9.96.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CEMEX, S.A.B. de C.V. produces, markets, distributes, and sells cement, ready-mix concrete, clinker, aggregates, and other construction materials for home construction and concrete pavement applications. Cemex SAB de CV has a market cap of $11.7 billion and is part of the industrial goods sector. Shares are down 2.3% year-to-date as of the close of trading on Friday. Currently there are 8 analysts that rate Cemex SAB de CV a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cemex SAB de CV as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full Cemex SAB de CV Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, DR Horton ( DHI) is down $0.14 (-0.5%) to $27.18 on light volume. Thus far, 1.8 million shares of DR Horton exchanged hands as compared to its average daily volume of 6.5 million shares. The stock has ranged in price between $26.75-$27.46 after having opened the day at $27.30 as compared to the previous trading day's close of $27.32.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

D.R. Horton, Inc. operates as a homebuilding company. It is engaged in the acquisition and development of land; and construction and sale of residential homes in 27 states and 79 markets in the United States under the names of D.R. DR Horton has a market cap of $10.0 billion and is part of the industrial goods sector. Shares are up 8.0% year-to-date as of the close of trading on Friday. Currently there are 7 analysts that rate DR Horton a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates DR Horton as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full DR Horton Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Lennar ( LEN) is down $0.37 (-0.7%) to $49.95 on light volume. Thus far, 887,509 shares of Lennar exchanged hands as compared to its average daily volume of 3.9 million shares. The stock has ranged in price between $49.26-$50.59 after having opened the day at $50.25 as compared to the previous trading day's close of $50.32.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lennar Corporation, together with its subsidiaries, engages in the homebuilding activities in the United States. Lennar has a market cap of $8.7 billion and is part of the industrial goods sector. Shares are up 12.3% year-to-date as of the close of trading on Friday. Currently there are 7 analysts that rate Lennar a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Lennar as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Lennar Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the materials & construction industry could consider SPDR S&P Homebuilders ETF ( XHB) while those bearish on the materials & construction industry could consider ProShares Short Basic Materials Fd ( SBM).

null